Mittwoch, 20. September 2017


  • Pressemitteilung BoxID 131202

TRIN Pharma appoints new CEO

Appenzell, Switzerland, (lifePR) - TRIN Pharma GmbH, specializing in the development of small molecule drugs for tumor treatment, has announced that effective October 6, 2009, Dr. Stefan Wohlfeil has been appointed new CEO of TRIN Pharma.

Stefan Wohlfeil previously held the position of Chief Medical Officer at TRIN Pharma. The change in management takes place at a time, where TRIN Pharma is moving its lead molecule TRIN 2755 into Phase I clinical development.

Dr. Rudolf Reiter, who held the position previously in addition to his role as CEO of Ergonex, will now focus entirely on his responsibility for Ergonex. Rudolf Reiter commented: "I am pleased to pass the leadership of TRIN Pharma on to Stefan Wohlfeil who has the right expertise to drive the clinical development of TRIN 2755. This will allow me to direct my full attention to Ergonex and the development of Terguride."

Stefan Wohlfeil said: "I am excited to take over from Rudolf Reiter at a time where our lead molecule is entering clinical development. I would like to thank Rudolf for his excellent work and many contributions during the build-up phase of TRIN Pharma."

TRIN PHARMA GmbH

TRIN Pharma GmbH develops new small molecule drugs for effective tumor treatment. The research is focused on innovative compounds with proprietary molecular structure, high selectivity and potent anti-tumor activity. TRIN Pharma's business objective is the development of its molecules into clinical studies and commercialization. TRIN Pharma is financed by High Tech Private Equity, Düsseldorf, Germany.

Diese Pressemitteilungen könnten Sie auch interessieren

Parkinson-Krankheit: früh erkennen, früh handeln

, Gesundheit & Medizin, Deutsche Gesellschaft für Neurologie e. V.

„Es gibt nicht nur eine Parkinson-Krankheit – es gibt viele“, sagte Professor Daniela Berg heute zum Auftakt des Neurologiekongresses in Leipzig....

"Gehirngesunde" Ernährung: wie Essen vor Demenz schützen kann

, Gesundheit & Medizin, Deutsche Gesellschaft für Neurologie e. V.

Altersforscher haben Nahrungsinhaltsstoff­e identifiziert, die Selbstreinigungsproz­esse in den Gehirnzellen ankurbeln und vor neurodegenerativen...

BPI zum TK-Innovationsreport: Therapieverbesserung braucht Vorrang vor Kostensteuerung

, Gesundheit & Medizin, Bundesverband der Pharmazeutischen Industrie e.V.

Der Bundesverband der Pharmazeutischen Industrie (BPI) kritisiert den verzerrten Blick der Techniker Krankenkasse (TK) auf die Patientenversorgung....

Disclaimer